Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management under the brand name Zepbound
AOD 9604 has been evaluated in rodent models of obesity
If you qualify, youll have a telehealth consultation with a board-certified physician who will review your medical history and prescribe the medication, if medically appropriate
9.4.3 Critically evaluates the safety and efficacy of traditional and pharmaceutical models as it applies to nutrition and dietetics
The D-Phe stereochemistry and Nle substitution were specifically selected to resist enzymatic proteolysis, as established in the precursor work (Sawyer 1980, PMID 6777774)
